NCT06345417View on ClinicalTrials.gov

Outcomes of Patient Blood Management in Severely Anemic Patients

Not yet recruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

May 1, 2025

Conditions
Severe Anemia
Interventions
OTHER

Patient Blood Management (PBM)

PBM is a strategy to manage the participant's own blood. Its focus is on anemia, bleeding and coagulation management.

BIOLOGICAL

Allogeneic transfusion

Anemia is treated by administering donor red cells, and bleeding or coagulopathy by plasma, platelets or other donor blood products.

Trial Locations (2)

99867

Helios Klinikum, Gotha

Unknown

Helios Klinikum, Erfurt

All Listed Sponsors
collaborator

HELIOS Hospital, Erfurt, Germany

OTHER

lead

Helios Klinik Gotha/Ohrdruf

OTHER

NCT06345417 - Outcomes of Patient Blood Management in Severely Anemic Patients | Biotech Hunter | Biotech Hunter